J. Desmeules

发表

Genetic polymorphisms and drug interactions modulating CYP 2 D 6 and CYP 3 A activities have a major effect on oxycodone analgesic efficacy and safetybph

D. Hochstrasser, Y. Daali, P. Dayer, 2010 .

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

D. Hochstrasser, Y. Daali, P. Dayer, 2010, British journal of pharmacology.

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

D. Hochstrasser, Y. Daali, P. Dayer, 2010, British journal of pharmacology.

Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach

Y. Daali, S. Rudaz, J. Desmeules, 2016, Clinical pharmacology and therapeutics.

Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model

Y. Daali, S. Rudaz, J. Desmeules, 2014, CPT: pharmacometrics & systems pharmacology.

Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management

C. Cedraschi, A. Allaz, E. Rapiti, 2004, Annals of the rheumatic diseases.

Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients.

Y. Daali, S. Cherkaoui, P. Dayer, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Adverse Drug Reactions Due to Opioid Use in Oldest-Old Patients Visiting the Emergency Unit of the Geneva Geriatric Hospital

D. Zekry, J. Desmeules, V. Piguet, 2022, The Journal of Frailty & Aging.

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection

Y. Daali, F. Negro, D. Moradpour, 2012, Journal of viral hepatitis.

Drug metabolic enzyme genotype-phenotype discrepancy: High phenoconversion rate in patients treated with antidepressants.

Y. Daali, J. Aubry, M. Besson, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS.

Y. Daali, J. Desmeules, A. Thomas, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

SP0065 Fibromyalgia: pain management strategies

C. Cedraschi, J. Desmeules, T. Vischer, 2001 .

The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction

D. Hochstrasser, Y. Daali, P. Dayer, 2009, The Pharmacogenomics Journal.

Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability.

Y. Daali, P. Dayer, P. Fontana, 2010, Current drug metabolism.

Detecting drug interactions using personal digital assistants in an out-patient clinic.

M Francis Dallenbach, P A Bovier, J Desmeules, 2007, QJM : monthly journal of the Association of Physicians.

The paraoxonase‐1 pathway is not a major bioactivation pathway of clopidogrel in vitro

Y. Daali, P. Dayer, J. Desmeules, 2012, British journal of pharmacology.

Oral Flurbiprofen Metabolic Ratio Assessment Using a Single‐Point Dried Blood Spot

Y. Daali, P. Dayer, J. Déglon, 2012, Clinical pharmacology and therapeutics.